US3331814A - Synthetic polypeptides of an l-imino acid and an l-amino acid - Google Patents

Synthetic polypeptides of an l-imino acid and an l-amino acid Download PDF

Info

Publication number
US3331814A
US3331814A US295223A US29522363A US3331814A US 3331814 A US3331814 A US 3331814A US 295223 A US295223 A US 295223A US 29522363 A US29522363 A US 29522363A US 3331814 A US3331814 A US 3331814A
Authority
US
United States
Prior art keywords
acid
imino
polypeptide
amino acid
synthetic polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US295223A
Inventor
Randall Alan Arthur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel UK PLC
Original Assignee
Courtaulds PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Courtaulds PLC filed Critical Courtaulds PLC
Application granted granted Critical
Publication of US3331814A publication Critical patent/US3331814A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F6/00Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
    • D01F6/58Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products
    • D01F6/68Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolycondensation products from polyaminoacids or polypeptides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06At least partially resorbable materials
    • A61L17/08At least partially resorbable materials of animal origin, e.g. catgut, collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06At least partially resorbable materials
    • A61L17/10At least partially resorbable materials containing macromolecular materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/06Wet spinning methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Definitions

  • a strand or filament used to sew together the open parts of a Wound is referred to as a suture; when used to tie blood vessels it is known as a ligature.
  • suture is used in this specification to refer to both sutures and ligatures.
  • Sutures are either absorbable or non-absorbable.
  • the only completely absorbable suture is of animal origin and is known, generically, as cat-gut.
  • This material is composed largely of the protein collagen, which is absorbed o digested, during the healing process, by the tissues in which it is embedded. The absorption is brought about by proteolytic enzymes in the tissues which hydrolyse the collagen into its component amino acids which are readily metabolised.
  • the present invention is a polypeptide subject to proteolysis, comprising a copolymer of an L-imino acid and an L-amino acid.
  • L-proline and L-hydroxyproline are the preferred imino acids and they may be used in conjunction with such amino acids as L-glutamic acid and L-alanine in forming the polypeptide.
  • the rate of proteolysis of the polypeptide increases with the proportion of the imino acid component and it is merely a matter of experiment to discover the ratio of imino acid to amino acid residues which endows the polypeptide with a desirable resistance or susceptibility to proteolysis.
  • the polypeptide need contain no more than from 5 to 15 percent of the imino acid, but it is also possible to slow the rate of proteolysis of the polypeptide containing this amount or more of the imino acid by tanning, as is done for cat-gut by transforming it to chromicised cat-gut for example.
  • polypeptide from a mixture of the N-carboxyanhydride derivatives of the amino-acid and the imino acid.
  • the mixture is reacted in an inert solvent for the polypeptide to form a viscous solution with evolution of carbon dioxide.
  • the solution of polypeptide may then be extruded to form filaments or films by contact with a coagulant o1- evaporation of the solvent, i.e. using ice wet spinning or dry-spinning techniques.
  • the films and filaments are strengthened and rendered less soluble by stretching.
  • the filaments are useful sutures and the films may be sliced to form sutures or used as absorbable panels in surgery.
  • the invention is illustrated by the following example.
  • the polypeptide solution could be cast into films or spun into filaments by extrusion into coagulants such as ether or ether/ acetone mixtures.
  • the unstretched filaments were found to be insoluble in water, readily soluble in dichloroacetic acid and trifluoracetic acid, and sparingly soluble in glacial acetic acid, formic acid, chloroform, methylene chloride and N,N-dimethyl formamide.
  • the filaments were stretched by 400 percent and this has the effect of reducing their solubility in all the above-mentioned solvents, as well as increasing the filament tenacity to 1.6- gram/ denier.
  • the absovbability of the sutures of the filamentary polypeptide was tested in vitro by incubation in media containing proteolytic enzymes such as trypsin and papain.
  • proteolytic enzymes such as trypsin and papain.
  • the method used was that employed by Lennox & Forss (Journal of the Society of Leather Trades Chemists, 36, 322) in their examination of the digestion of tanned collagen by enzymes. The results of these determinations showed that the polypeptide had a rate of proteolysis similar to that of chromicised cat-gut.
  • a solid, fiber forming, water insoluble polypeptide copolymer capable of proteolysis consisting essentially of an L-imino acid selected from the group consisting of L-proline and L-hydroxy proline and an L-amino acid selected from the group consisting of L-glutamic acid and L-alanine.

Description

United States Patent 3,331,814 SYNTHETIC POLYPEPTTDES OF AN L-IMINO ACID AND AN L-AMINO ACID Alan Arthur Randall, Maidenhead, England, assignor to Courtaulds Limited, London, England, a British com- P y N0 Drawing. Filed July 15, 1963, Ser. No. 295,223 Claims priority, application Great Britain, Aug. 24, 1962, 32,561/62 4 Claims. (Cl. 260-78) This invention is concerned with synthetic polypeptides which are hydrolysable by enzymes and which may be formed into filaments or films.
In the practice of surgery, a strand or filament used to sew together the open parts of a Wound, is referred to as a suture; when used to tie blood vessels it is known as a ligature. The word suture is used in this specification to refer to both sutures and ligatures.
Sutures are either absorbable or non-absorbable. The only completely absorbable suture is of animal origin and is known, generically, as cat-gut. This material is composed largely of the protein collagen, which is absorbed o digested, during the healing process, by the tissues in which it is embedded. The absorption is brought about by proteolytic enzymes in the tissues which hydrolyse the collagen into its component amino acids which are readily metabolised.
The rate of proteolysis of collagen can be slowed by tanning the protein, as is done, for example, in the production of chromicised cat-gut. In this way, a number of sutures having difierent life-spans in proteolytic environments, may be derived :from a single sample of raw cat-gut, simply by varying the severity of the tanning process.
We have made a fibre-forming synthetic polypeptide which has a property similar to that of collagen, in that it is subject to proteolysis.
Accordingly, the present invention is a polypeptide subject to proteolysis, comprising a copolymer of an L-imino acid and an L-amino acid.
L-proline and L-hydroxyproline are the preferred imino acids and they may be used in conjunction with such amino acids as L-glutamic acid and L-alanine in forming the polypeptide.
The rate of proteolysis of the polypeptide increases with the proportion of the imino acid component and it is merely a matter of experiment to discover the ratio of imino acid to amino acid residues which endows the polypeptide with a desirable resistance or susceptibility to proteolysis.
For use in sutures, the polypeptide need contain no more than from 5 to 15 percent of the imino acid, but it is also possible to slow the rate of proteolysis of the polypeptide containing this amount or more of the imino acid by tanning, as is done for cat-gut by transforming it to chromicised cat-gut for example.
We have made the polypeptide from a mixture of the N-carboxyanhydride derivatives of the amino-acid and the imino acid. The mixture is reacted in an inert solvent for the polypeptide to form a viscous solution with evolution of carbon dioxide. The solution of polypeptide may then be extruded to form filaments or films by contact with a coagulant o1- evaporation of the solvent, i.e. using ice wet spinning or dry-spinning techniques. The films and filaments are strengthened and rendered less soluble by stretching.
The filaments are useful sutures and the films may be sliced to form sutures or used as absorbable panels in surgery.
The invention is illustrated by the following example.
EXAMPLE A mixture of 1 gram of L-proline N-carboxy anhydride and 11.93 grams of 'y-methyl L- glutamate N-carboxy anhydride was dissolved with warming in a mix ture of ethyl acetate (19.4 ml.) and methylene chloride (35.8 ml.). The initiator, 9.5 ml. of N/lO tri-n-butylamine in methylene chloride, was added and the polymerisation took place over a period of 15 hours at 40 C.
The polypeptide solution could be cast into films or spun into filaments by extrusion into coagulants such as ether or ether/ acetone mixtures. The unstretched filaments were found to be insoluble in water, readily soluble in dichloroacetic acid and trifluoracetic acid, and sparingly soluble in glacial acetic acid, formic acid, chloroform, methylene chloride and N,N-dimethyl formamide. The filaments were stretched by 400 percent and this has the effect of reducing their solubility in all the above-mentioned solvents, as well as increasing the filament tenacity to 1.6- gram/ denier.
The absovbability of the sutures of the filamentary polypeptide was tested in vitro by incubation in media containing proteolytic enzymes such as trypsin and papain. The method used was that employed by Lennox & Forss (Journal of the Society of Leather Trades Chemists, 36, 322) in their examination of the digestion of tanned collagen by enzymes. The results of these determinations showed that the polypeptide had a rate of proteolysis similar to that of chromicised cat-gut.
When a strand of the polypeptide was immersed in the papain solution at 50 C. for one hour, it sutfered a loss of weight of 11.4 percent.
What Iclaim is:
' 1. A solid, fiber forming, water insoluble polypeptide copolymer capable of proteolysis consisting essentially of an L-imino acid selected from the group consisting of L-proline and L-hydroxy proline and an L-amino acid selected from the group consisting of L-glutamic acid and L-alanine.
2. The copolymer claimed in claim 1 in which the proportion of L-imino acid is between about 5 and about 15% by weight and the proportion of L-amino acid is between about and about by weight.
3. A filament formed from the copolymer of claim 1.
4. A film formed from the copolymer of claim 1.
References Cited UNITED STATES PATENTS 3,052,655 9/1962 Fox et al. 26078 3,076,790 2/1963 Fox et al. 260 78 3,089,749 5/1963 Ballard 260'-78 WILLIAM H. SHORT, Primary Examiner.
H. D. ANDERSON, Assistant Examiner.

Claims (1)

1. A SOLID, FIBER FORMING, WATER INSOLUBLE POLYPEPTIDE COPOLYMER CAPABLE OF PROTEOLYSIS CONSISTING ESSENTIALLY OF AN L-IMINO ACID SELECTED FROM THE GROUP CONSISTING OF L-PROLINE AND L-HYDROXY PROLINE AND AN L-AMINO ACID SELECTED FROM THE GROUP CONSISTING OF L-GLUTAMIC ACID AND L-ALININE.
US295223A 1962-08-24 1963-07-15 Synthetic polypeptides of an l-imino acid and an l-amino acid Expired - Lifetime US3331814A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32561/62A GB1049290A (en) 1962-08-24 1962-08-24 Synthetic polypeptides

Publications (1)

Publication Number Publication Date
US3331814A true US3331814A (en) 1967-07-18

Family

ID=10340564

Family Applications (1)

Application Number Title Priority Date Filing Date
US295223A Expired - Lifetime US3331814A (en) 1962-08-24 1963-07-15 Synthetic polypeptides of an l-imino acid and an l-amino acid

Country Status (9)

Country Link
US (1) US3331814A (en)
AT (1) AT262517B (en)
BE (1) BE636530A (en)
CH (1) CH431552A (en)
DE (1) DE1495312A1 (en)
FR (1) FR1367282A (en)
GB (1) GB1049290A (en)
NL (1) NL297020A (en)
SE (1) SE303832B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626948A (en) * 1968-12-23 1971-12-14 American Cyanamid Co Absorbable polyglycolic acid suture of enhanced in-vivo strength retention
US3867520A (en) * 1971-04-14 1975-02-18 Ajinomoto Kk Medicated polyamino acid film for occlusive dressing therapy
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
US4915893A (en) * 1982-07-16 1990-04-10 Medtronic, Inc. Method of preparing polyester filament material
US4955913A (en) * 1985-03-28 1990-09-11 Robinson Walter C Surgical tie
US5101011A (en) * 1990-07-20 1992-03-31 Ajinomoto Co., Inc. Aligning agent for liquid crystals comprising poly alpha-amino acid having no optical activity
US5110852A (en) * 1982-07-16 1992-05-05 Rijksuniversiteit Te Groningen Filament material polylactide mixtures
WO2000052078A1 (en) * 1999-03-05 2000-09-08 Innovative Technologies, Llc Use of protein conformation for the protection and release of chemical compounds
US20020128177A1 (en) * 1999-03-05 2002-09-12 Kirk Randal J. Use of protein conformation for the protection and release of chemical compounds
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US20070203055A1 (en) * 2003-09-30 2007-08-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20110046226A1 (en) * 2001-08-22 2011-02-24 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773737A (en) * 1971-06-09 1973-11-20 Sutures Inc Hydrolyzable polymers of amino acid and hydroxy acids
CN113150064B (en) * 2021-04-14 2023-04-11 中山大学 Artificial synthesis method and application of antibacterial and insect-resistant peptide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052655A (en) * 1958-08-01 1962-09-04 Sidney W Fox Thermal polymerization of amino acid mixtures containing aspartic acid or a thermal precursor of aspartic acid
US3076790A (en) * 1958-08-01 1963-02-05 Sidney W Fox Method of making copolymers of amino acids containing glutamic acid
US3089749A (en) * 1958-04-21 1963-05-14 Courtaulds Ltd Production of artificial threads

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089749A (en) * 1958-04-21 1963-05-14 Courtaulds Ltd Production of artificial threads
US3052655A (en) * 1958-08-01 1962-09-04 Sidney W Fox Thermal polymerization of amino acid mixtures containing aspartic acid or a thermal precursor of aspartic acid
US3076790A (en) * 1958-08-01 1963-02-05 Sidney W Fox Method of making copolymers of amino acids containing glutamic acid

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626948A (en) * 1968-12-23 1971-12-14 American Cyanamid Co Absorbable polyglycolic acid suture of enhanced in-vivo strength retention
US3867520A (en) * 1971-04-14 1975-02-18 Ajinomoto Kk Medicated polyamino acid film for occlusive dressing therapy
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
US4915893A (en) * 1982-07-16 1990-04-10 Medtronic, Inc. Method of preparing polyester filament material
US5110852A (en) * 1982-07-16 1992-05-05 Rijksuniversiteit Te Groningen Filament material polylactide mixtures
US4955913A (en) * 1985-03-28 1990-09-11 Robinson Walter C Surgical tie
US5101011A (en) * 1990-07-20 1992-03-31 Ajinomoto Co., Inc. Aligning agent for liquid crystals comprising poly alpha-amino acid having no optical activity
US20020128177A1 (en) * 1999-03-05 2002-09-12 Kirk Randal J. Use of protein conformation for the protection and release of chemical compounds
WO2000052078A1 (en) * 1999-03-05 2000-09-08 Innovative Technologies, Llc Use of protein conformation for the protection and release of chemical compounds
AU771188B2 (en) * 1999-03-05 2004-03-18 Shire Llc Use of protein conformation for the protection and release of chemical compounds
US7018654B2 (en) 1999-03-05 2006-03-28 New River Pharmaceuticals Inc. Pharmaceutical composition containing an active agent in an amino acid copolymer structure
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US20040127397A1 (en) * 2000-08-22 2004-07-01 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20110046226A1 (en) * 2001-08-22 2011-02-24 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
US8343927B2 (en) 2001-08-22 2013-01-01 Shire Llc Pharmaceutical compositions for prevention of overdose or abuse
US20070203055A1 (en) * 2003-09-30 2007-08-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US8106016B2 (en) 2003-09-30 2012-01-31 Shire Llc Compounds and compositions for prevention of overdose of oxycodone

Also Published As

Publication number Publication date
NL297020A (en)
DE1495312A1 (en) 1969-03-06
FR1367282A (en) 1964-07-17
GB1049290A (en) 1966-11-23
BE636530A (en)
SE303832B (en) 1968-09-09
CH431552A (en) 1967-03-15
AT262517B (en) 1968-06-10

Similar Documents

Publication Publication Date Title
US3331814A (en) Synthetic polypeptides of an l-imino acid and an l-amino acid
NO149835B (en) METHOD AND DEVICE FOR AA LOCATE THE EXACT LOCATION OF HIDDEN GOODS
Mathur et al. The dissolution and characterization of Bombyx mori silk fibroin in calcium nitrate‐methanol solution and the regeneration of films
US3371069A (en) Filaments and surgical sutures of polyl-glutamic acid partly esterified with lower alkanols and process therefor
US5349045A (en) Polymer derived from cyclic amide and medical devices manufactured therefrom
US6165202A (en) Absorbable polymers and surgical articles fabricated therefrom
US5171505A (en) Process for spinning polypeptide fibers
US6235869B1 (en) Absorbable polymers and surgical articles fabricated therefrom
JP4463702B2 (en) Stretchable collagen molded body, production method and use thereof
CN113171488B (en) Absorbable suture line and preparation method thereof
US3527225A (en) Resorbable surgical sutures from fibrous proteins
EP0553883A1 (en) Polyamide monofilament suture manufactured from higher order polyamide
US4767827A (en) Artificial hair comprising poly alpha amino acid having pendant mercapto or disulfide groups
CN1021953C (en) Collagen-polyvinyl alcoholic operation sutures and manufacturing method thereof
KR100451112B1 (en) Kitosan staple fibers, chemically modified kitosan fibers, and a process for preparation thereof
US3374103A (en) Collagen fibril and neutral salt composition
Tachibana et al. The use of chitin as a new absorbable suture material—an experimental study
Hayashi et al. Enzymatic hydrolysis of copoly-(N-hydroxyalkyll-glutamine/γ-methyl l-glutamate) fibres
Cloutier et al. Solid-state nuclear magnetic resonance (NMR) spectroscopy reveals distinctive protein dynamics in closely related spider silks
KR960015655B1 (en) Resolvable chitin fiber and production process thereof
CA2347790C (en) Absorbable polymers and surgical articles fabricated therefrom
GB1401215A (en) Process for solid polyamino acid containing repeating aspartic and glutamic acid units
CN107778506B (en) Degradable film material, preparation method and application thereof
US3345306A (en) Tubing fluid containing an amino acid
Howitt THE STRUCTURE OF TEXTILE FIBRES V. THE STRUCTURE OF PROTEINS—SILK